These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10844315)

  • 1. [Bioavailability of antibiotics].
    Robert PY; Tassy A
    J Fr Ophtalmol; 2000 May; 23(5):510-3; quiz 523. PubMed ID: 10844315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of gentamicin to the rabbit eye by drug-loaded hydrogel iontophoresis.
    Eljarrat-Binstock E; Raiskup F; Stepensky D; Domb AJ; Frucht-Pery J
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2543-8. PubMed ID: 15277475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics bioavailability in acute experimental pancreatitis.
    Trudel JL; Wittnich C; Brown RA
    J Am Coll Surg; 1994 May; 178(5):475-9. PubMed ID: 8167885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ocular drug penetration].
    Dupin O; Trinquand C
    J Fr Ophtalmol; 2000 May; 23(5):501-4; quiz 523. PubMed ID: 10844313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A primer on topical antibiotics for the skin and eyes.
    Noah S
    J Drugs Dermatol; 2008 Apr; 7(4):409-15. PubMed ID: 18459527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of moxifloxacin as shown in animal and in vitro studies.
    McGee DH; Holt WF; Kastner PR; Rice RL
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S46-54. PubMed ID: 16257310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin.
    Kuehne JJ; Yu AL; Holland GN; Ramaswamy A; Taban R; Mondino BJ; Yu F; Rayner SA; Giese MJ
    Am J Ophthalmol; 2004 Oct; 138(4):547-53. PubMed ID: 15488779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.
    Stroman DW; Dajcs JJ; Cupp GA; Schlech BA
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S16-31. PubMed ID: 16257308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bioavailability of antiinflammatory drugs].
    Cochereau I
    J Fr Ophtalmol; 2000 May; 23(5):514-7; quiz 523. PubMed ID: 10844316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative review of topical ophthalmic antibacterial preparations.
    Robert PY; Adenis JP
    Drugs; 2001; 61(2):175-85. PubMed ID: 11270936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.
    Robertson SM; Curtis MA; Schlech BA; Rusinko A; Owen GR; Dembinska O; Liao J; Dahlin DC
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S32-45. PubMed ID: 16257309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal penetration of fluoroquinolones: aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops.
    Koch HR; Kulus SC; Roessler M; Ropo A; Geldsetzer K
    J Cataract Refract Surg; 2005 Jul; 31(7):1377-85. PubMed ID: 16105610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of old-generation antibiotics to address current need for new antibiotics.
    Falagas ME; Grammatikos AP; Michalopoulos A
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):593-600. PubMed ID: 18847400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.
    Hariprasad SM; Shah GK; Chi J; Prince RA
    J Cataract Refract Surg; 2005 Nov; 31(11):2142-6. PubMed ID: 16412929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple drug-resistant Alcaligenes xylosoxidans keratitis in a sanitation worker.
    Kiernan DF; Chin EK; Sclafani LA; Saidel MA
    Eye Contact Lens; 2009 Jul; 35(4):212-4. PubMed ID: 19516143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial agents for ocular therapeutics.
    Kern TJ
    Vet Clin North Am Small Anim Pract; 2004 May; 34(3):655-68. PubMed ID: 15110977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial keratitis after corneal collagen crosslinking.
    Pérez-Santonja JJ; Artola A; Javaloy J; Alió JL; Abad JL
    J Cataract Refract Surg; 2009 Jun; 35(6):1138-40. PubMed ID: 19465303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration and bioavailability of ciprofloxacin and teicoplanin in the cornea.
    Kaye SB; Neal T; Nicholson S; Szkurlat J; Bamber S; Baddon AC; Anderson S; Seddon K; Dwyer N; Lovering AM; Smith G
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3176-84. PubMed ID: 19218614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of polyvinyl alcohol-gelatin membranes for antibiotic delivery in the eye.
    Jain D; Carvalho E; Banthia AK; Banerjee R
    Drug Dev Ind Pharm; 2011 Feb; 37(2):167-77. PubMed ID: 21073319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular bacterial infections: current and future treatment options.
    Kowalski RP; Dhaliwal DK
    Expert Rev Anti Infect Ther; 2005 Feb; 3(1):131-9. PubMed ID: 15757463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.